Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Explore this paper's citation graph

Summary

Since the major defect leading to a decrease in beta-cell mass in type 2 diabetes is increased apoptosis, while new islet formation and Beta-cell replication are normal, therapeutic approaches designed to arrest apoptosis could be a significant new development in the management of type 1 diabetes.

Type
article
Published
2003-01-01
Cited by
2,025
References
0

Keywords

Neogenesis, Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes

References

Cited by

Related papers